FDA, Journey
Fortress Biotech, Inc. (NASDAQ: FBIO) announced through its majority-controlled subsidiary, Journey Medical Corporation, that the U.S. Food and Drug Administration (FDA) has approved Emrosiâ„¢ ...
Journey Medical (NASDAQ:DERM) shares are trading higher Monday after the company announced the U.S. Food and Drug ...
Dermatology drugmaker Journey Medical has trekked its Dr. Reddy’s Laboratories-partnered rosacea med across the FDA finish line as Emrosi. | The drug proved superiority in clearing lesions over ...
Journey Medical (DERM) presented data assessing the dermal and systemic pharmacokinetics of oral DFD-29 versus oral Doxycycline 40 mg capsules ...
PhotonPharma Inc., which specializes in tumor-specific immune therapies, has hired Derek Brown as its new CEO as the company ...
Zacks.com on MSN1d
Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock?Journey Medical (DERM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price ...
Poster Presented on Dermal and Systemic Pharmacokinetics of Oral DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) versus Oral ...
Convenience stores are offering more and better — though not necessarily healthier — choices, seeking to be an alternative to ...
Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback